{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T19:08:54Z","timestamp":1773428934800,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"name":"State of Hungary"},{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","award":["T\u00c1MOP 4.2.4. A\/2-11-1-2012-0001"],"award-info":[{"award-number":["T\u00c1MOP 4.2.4. A\/2-11-1-2012-0001"]}],"id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","award":["T\u00c1MOP-4.2.2.A-11\/1\/KONV-2012-0031"],"award-info":[{"award-number":["T\u00c1MOP-4.2.2.A-11\/1\/KONV-2012-0031"]}],"id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Research, Development and Innovation (NFKI)","award":["OTKA 115723"],"award-info":[{"award-number":["OTKA 115723"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.clinbiochem.2016.03.011","type":"journal-article","created":{"date-parts":[[2016,5,9]],"date-time":"2016-05-09T09:33:17Z","timestamp":1462786397000},"page":"862-867","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Paraoxonase-1 arylesterase activity is an independent predictor of myeloperoxidase levels in overweight patients with or without cardiovascular complications"],"prefix":"10.1016","volume":"49","author":[{"given":"No\u00e9mi","family":"Zs\u00edros","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e9ter","family":"Koncsos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajnalka","family":"L\u0151rincz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ildik\u00f3","family":"Seres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f3nika","family":"Katk\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Szentp\u00e9teri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikt\u00f3ria E.","family":"Varga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e9ter","family":"F\u00fcl\u00f6p","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gy\u00f6rgy","family":"Paragh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariann","family":"Harangi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2016.03.011_bb0005","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0140-6736(05)67483-1","article-title":"Obesity","volume":"366","author":"Haslam","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.clinbiochem.2016.03.011_bb0010","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jjcc.2013.11.006","article-title":"Adipokines: a link between obesity and cardiovascular disease","volume":"63","author":"Nakamura","year":"2014","journal-title":"J. Cardiol."},{"key":"10.1016\/j.clinbiochem.2016.03.011_bb0015","doi-asserted-by":"crossref","first-page":"S346","DOI":"10.1194\/jlr.R800086-JLR200","article-title":"Myeloperoxidase, modified lipoproteins, and atherogenesis","volume":"50","author":"Nicholls","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.clinbiochem.2016.03.011_bb0020","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejim.2005.09.015","article-title":"Plasma markers of endothelial dysfunction in type 2 diabetics","volume":"17","author":"Moldoveanu","year":"2006","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.clinbiochem.2016.03.011_bb0025","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1172\/JCI67478","article-title":"Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex","volume":"123","author":"Huang","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clinbiochem.2016.03.011_bb0030","doi-asserted-by":"crossref","first-page":"30825","DOI":"10.1074\/jbc.M109.047605","article-title":"Modification of high density lipoprotein by myeloperoxidase generates a pro-inflammatory particle","volume":"284","author":"Undurti","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clinbiochem.2016.03.011_bb0035","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1172\/JCI200421109","article-title":"Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease","volume":"114","author":"Zheng","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clinbiochem.2016.03.011_bb0040","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.atherosclerosis.2013.11.075","article-title":"Myeloperoxidase levels predict accelerated progression of coronary atherosclerosis in diabetic patients: insights from intravascular ultrasound","volume":"232","author":"Kataoka","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2016.03.011_bb0045","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cca.2014.09.016","article-title":"Paraoxonase 1 and HDL maturation","volume":"439","author":"Gugliucci","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.clinbiochem.2016.03.011_bb0050","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1161\/01.CIR.0000070954.00271.13","article-title":"Low paraoxonase activity predicts coronary events in the Caerphilly prospective study","volume":"107","author":"Mackness","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2016.03.011_bb0055","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000045161","article-title":"The serum paraoxonase activity in patients with chronic renal failure and hyperlipidemia","volume":"80","author":"Paragh","year":"1998","journal-title":"Nephron"},{"key":"10.1016\/j.clinbiochem.2016.03.011_bb0060","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1210\/jc.2004-0486","article-title":"Paraoxonase activity in high-density lipoproteins: a comparison between healthy and obese females","volume":"90","author":"Ferretti","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.clinbiochem.2016.03.011_bb0065","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2362.2007.01769.x","article-title":"Genetic and environmental determinants of the PON-1 phenotype","volume":"37","author":"Roest","year":"2007","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.clinbiochem.2016.03.011_bb0070","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.numecd.2008.12.005","article-title":"Myeloperoxidase and paraoxonase-1 in type 2 diabetic patients","volume":"19","author":"Jornayvaz","year":"2009","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.clinbiochem.2016.03.011_bb0075","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.cardiores.2005.12.002","article-title":"Structure and function of matrix metalloproteinases and TIMPs","volume":"69","author":"Nagase","year":"2006","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.clinbiochem.2016.03.011_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-800263-6.00001-X","article-title":"Matrix metalloproteinases in coronary artery disease","volume":"64","author":"Mittal","year":"2014","journal-title":"Adv. Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2016.03.011_bb0085","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.atherosclerosis.2014.06.007","article-title":"Evidence for an exclusive association of matrix metalloproteinase-9 with dysfunctional high-density lipoprotein: a novel finding","volume":"236","author":"Sini","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2016.03.011_bb0090","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000430885","article-title":"The long-term influence of tissue inhibitor of matrix metalloproteinase-1 in patients with mild to moderate coronary artery lesions in a Chinese population: a 7-year follow-up study","volume":"132","author":"Wang","year":"2015","journal-title":"Cardiology"},{"key":"10.1016\/j.clinbiochem.2016.03.011_bb0095","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1067\/mhj.2001.112238","article-title":"Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome","volume":"141","author":"Inokubo","year":"2001","journal-title":"Am. Heart J."},{"key":"10.1016\/j.clinbiochem.2016.03.011_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2006.02.029","article-title":"Tissue inhibitor of metalloproteinase-1 (TIMP-1) is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction","volume":"151","author":"Cavusoglu","year":"2006","journal-title":"Am. Heart. J."},{"key":"10.1016\/j.clinbiochem.2016.03.011_bb0105","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.amjcard.2010.03.060","article-title":"Usefulness of plasma tissue inhibitors of metalloproteinases as markers of prognosis after acute myocardial infarction","volume":"106","author":"Kelly","year":"2010","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.clinbiochem.2016.03.011_bb0110","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.atherosclerosis.2009.10.046","article-title":"Effects of rosuvastatin on myeloperoxidase levels in patients with chronic heart failure: a randomized placebo-controlled study","volume":"210","author":"Andreou","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2016.03.011_bb0115","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/jcph.146","article-title":"Simvastatin therapy decreases MMP-9 levels in obese women","volume":"53","author":"Andrade","year":"2013","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.clinbiochem.2016.03.011_bb0120","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.trsl.2009.01.007","article-title":"Atorvastatin effect on the distribution of high-density lipoprotein subfractions and human paraoxonase activity","volume":"153","author":"Harangi","year":"2009","journal-title":"Transl. Res."},{"key":"10.1016\/j.clinbiochem.2016.03.011_bb0125","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/sj.ijo.0803794","article-title":"Matrix metalloproteinases 2 and 9 and their tissue inhibitors 1 and 2 in premenopausal obese women: relationship to cardiac function","volume":"32","author":"Kosmala","year":"2008","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.clinbiochem.2016.03.011_bb0130","doi-asserted-by":"crossref","first-page":"729515","DOI":"10.1155\/2013\/729515","article-title":"The impact of rapid weight loss on oxidative stress markers and the expression of the metabolic syndrome in obese individuals","volume":"2013","author":"Tumova","year":"2013","journal-title":"J. Obes."},{"key":"10.1016\/j.clinbiochem.2016.03.011_bb0135","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1111\/jcmm.12282","article-title":"Association of chemerin with oxidative stress, inflammation and classical adipokines in non-diabetic obese patients","volume":"18","author":"F\u00fcl\u00f6p","year":"2014","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.clinbiochem.2016.03.011_bb0140","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000045489","article-title":"Serum paraoxonase activity changes in uremic and kidney-transplanted patients","volume":"83","author":"Paragh","year":"1999","journal-title":"Nephron"},{"key":"10.1016\/j.clinbiochem.2016.03.011_bb0145","first-page":"1126","article-title":"The human serum paraoxonase\/arylesterase polymorphism","volume":"35","author":"Eckerson","year":"1983","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.clinbiochem.2016.03.011_bb0150","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0090-9556(25)07066-7","article-title":"Characteristics of the genetically determined allozymic forms of human serum paraoxonase\/arylesterase","volume":"19","author":"Smolen","year":"1991","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.clinbiochem.2016.03.011_bb0155","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1172\/JCI117619","article-title":"Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques","volume":"94","author":"Galis","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clinbiochem.2016.03.011_bb0160","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.atherosclerosis.2013.08.037","article-title":"Gender-specific correlation between plasma myeloperoxidase levels and serum high-density lipoprotein-associated paraoxonase-1 levels in patients with stable and unstable coronary artery disease","volume":"231","author":"Yunoki","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2016.03.011_bb0165","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.atherosclerosis.2014.03.009","article-title":"Serum myeloperoxidase\/paraoxonase 1 ratio as potential indicator of dysfunctional high-density lipoprotein and risk stratification in coronary artery disease","volume":"234","author":"Haraguchi","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2016.03.011_bb0170","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1093\/brain\/awv184","article-title":"Effect of the myeloperoxidase inhibitor AZD3241 on microglia: a PET study in Parkinson's disease","volume":"138","author":"Jucaite","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.clinbiochem.2016.03.011_bb0175","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1194\/jlr.M038273","article-title":"N-acetyl lysyltyrosylcysteine amide inhibits myeloperoxidase, a novel tripeptide inhibitor","volume":"54","author":"Zhang","year":"2013","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.clinbiochem.2016.03.011_bb0180","doi-asserted-by":"crossref","first-page":"8513","DOI":"10.1021\/acs.jmedchem.5b00963","article-title":"Discovery of 2-(6-(5-Chloro-2-methoxyphenyl)-4-oxo-2-thioxo-3,4-dihydropyrimidin-1(2H)-yl)acetamide (PF-06282999): a highly selective mechanism-based myeloperoxidase inhibitor for the treatment of cardiovascular diseases","volume":"58","author":"Ruggeri","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.clinbiochem.2016.03.011_bb0185","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1124\/jpet.114.221788","article-title":"PF-1355, a mechanism-based myeloperoxidase inhibitor, prevents immune complex vasculitis and anti-glomerular basement membrane glomerulonephritis","volume":"353","author":"Zheng","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000991201630039X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000991201630039X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:48:50Z","timestamp":1757864930000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000991201630039X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S000991201630039X"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2016.03.011","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paraoxonase-1 arylesterase activity is an independent predictor of myeloperoxidase levels in overweight patients with or without cardiovascular complications","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2016.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}